Rick Maffei, Author at MPR Mon, 15 Apr 2024 19:01:50 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.empr.com/wp-content/uploads/sites/7/2023/03/cropped-empr-32x32.jpg Rick Maffei, Author at MPR 32 32 March 2024 Recap of Drug Updates https://www.empr.com/home/news/march-2024-recap-of-drug-updates/ Thu, 11 Apr 2024 20:35:34 +0000 https://www.empr.com/?p=218636 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of March. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
ALTOPREV (Lovastatin) X X X X X      
BESPONSA (Inotuzumab ozogamicin) X X   X        
BREYANZI (Lisocabtagene maraleucel) X X       X    
DOVATO (Dolutegravir) X X   X X   X  
FANAPT (Iloperidone) X X   X   X    
FURADANTIN (Nitrofurantoin)   X X X     X  
LIVMARLI (Maralixibat) X X X X   X    
VAGIFEM (Estradiol [as hemihydrate])     X X X X    
VYTORIN (Ezetimibe, simvastatin) X X X X X      
ZOKINVY (Lonafarnib)   X X X X      
Review more drug monograph updates

]]> February 2024 Recap of Drug Updates https://www.empr.com/home/news/february-2024-recap-of-drug-updates/ Fri, 01 Mar 2024 21:12:07 +0000 https://www.empr.com/?p=216492 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of February. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
BALVERSA (Erdafitinib) X X   X X X    
BELBUCA (Buprenorphine) X     X   X    
BILTRICIDE (Praziquantel)     X   X X    
BOSULIF (Bosutinib) X X       X X  
CETROTIDE (Cetrorelix [as acetate])     X  X   X    
DUPIXENT (Dupilumab) X X         X  
GAMMAGARD LIQUID (Immune globulin [human]) X X   X   X   X
HYQVIA (Immune globulin [human], recombinant human hyaluronidase) X X X     X    
MS CONTIN (Morphine sulfate) X     X   X    
XALKORI (Crizotinib)    X   X     X  
Review more drug monograph updates

]]> January 2024 Recap of Drug Updates https://www.empr.com/home/news/january-2024-recap-of-drug-updates/ Fri, 09 Feb 2024 14:17:14 +0000 https://www.empr.com/?p=215282 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of January. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
BALVERSA (Erdafitinib) X X   X X X    
BELBUCA (Buprenorphine) X     X   X    
BILTRICIDE (Praziquantel)     X   X X    
BOSULIF (Bosutinib) X X       X X  
CETROTIDE (Cetrorelix [as acetate])     X  X   X    
DUPIXENT (Dupilumab) X X         X  
GAMMAGARD LIQUID (Immune globulin [human]) X X   X   X   X
HYQVIA (Immune globulin [human], recombinant human hyaluronidase) X X X     X    
MS CONTIN (Morphine sulfate) X     X   X    
XALKORI (Crizotinib)    X   X     X  
Review more drug monograph updates

]]> December 2023 Recap of Drug Updates https://www.empr.com/home/news/december-2023-recap-of-drug-updates/ Thu, 04 Jan 2024 15:44:41 +0000 https://www.empr.com/?p=213443 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of December. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
COTEMPLA XR-ODT (Methylphenidate)       X X X    
CRESEMBA (Isavuconazonium sulfate)   X   X X   X   
DESOXYN (Methamphetamine HCl)     X X   X    
DEXEDRINE SPANSULE (Dextroamphetamine sulfate)     X X        
DYANAVEL XR ORAL SUSPENSION (Amphetamine)   X   X     X  
ORENCIA (Abatacept) X X            
SARCLISA (Isatuximab-irfc)       X X      
TARPEYO (Budesonide) X X   X        
TIROSINT-SOL (Levothyroxine sodium)   X   X X      
WELIREG (Belzutifan) X     X   X    
Review more drug monograph updates

]]> Telomere-Targeting Agent Gets Orphan Drug Status for Glioblastoma Treatment https://www.empr.com/home/news/drugs-in-the-pipeline/telomere-targeting-agent-gets-orphan-drug-status-for-glioblastoma-treatment/ Thu, 07 Dec 2023 16:17:35 +0000 ]]> ]]> Likmez, an Oral Suspension Formulation of Metronidazole, Now Available https://www.empr.com/home/news/likmez-an-oral-suspension-formulation-of-metronidazole-now-available/ Thu, 07 Dec 2023 16:16:42 +0000 ]]> ]]> Xtandi Gains Approval for Nonmetastatic Castration-Sensitive Prostate Cancer https://www.empr.com/home/news/xtandi-gains-approval-for-nonmetastatic-castration-sensitive-prostate-cancer/ Thu, 07 Dec 2023 16:15:29 +0000 Prostate cancer results]]> Prostate cancer results]]> FDA Panel Votes Against Gefapixant for Chronic Cough https://www.empr.com/home/news/drugs-in-the-pipeline/fda-panel-votes-against-gefapixant-for-chronic-cough/ Thu, 07 Dec 2023 16:14:17 +0000 ]]> ]]> November 2023 Recap of Drug Updates https://www.empr.com/home/news/november-2023-recap-of-drug-updates/ Fri, 01 Dec 2023 16:13:37 +0000 https://www.empr.com/?p=211231 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of November. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
ADZENYS XR-ODT (Amphetamine)     X X        
AZSTARYS (Serdexmethylphenidate, dexmethylphenidate)       X X X    
BREO ELLIPTA (Fluticasone furoate, vilanterol) X X            
CONCERTA (Methylphenidate)     X X X X    
COPAXONE (Glatiramer acetate)   X   X        
DAYTRANA (Methylphenidate)     X X X X     
ENBREL (Etanercept) X X         X  
IDACIO (Adalimumab-aacf) X X         X   
KINEVAC (Sincalide)     X X X      
MULTAQ (Dronedarone)     X X   X X  
Review more drug monograph updates

]]> FDA Drug Approval Decisions Expected in November 2023 https://www.empr.com/home/news/drugs-in-the-pipeline/fda-drug-approval-decisions-expected-in-november-2023/ Mon, 20 Nov 2023 23:15:19 +0000 ]]> ]]> ACIP Votes for Routine Use of Jynneos in Adults at Risk of Mpox Infection https://www.empr.com/home/news/acip-votes-for-routine-use-of-jynneos-in-adults-at-risk-of-mpox-infection/ Mon, 20 Nov 2023 23:13:47 +0000 ]]> ]]> Family Dollar Initiates Large Recall of OTC Drugs, Medical Devices https://www.empr.com/home/news/safety-alerts-and-recalls/family-dollar-drugs-medical-devices-recalled/ Tue, 14 Nov 2023 18:21:47 +0000 ]]> ]]> October 2023 Recap of Drug Updates https://www.empr.com/home/news/october-2023-recap-of-drug-updates/ Fri, 03 Nov 2023 20:12:31 +0000 https://www.empr.com/?p=209609 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of October. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
ABRILADA (Adalimumab-afzb) X X         X  
BRAFTOVI (Encorafenib) X X   X   X    
ENTYVIO (Vedolizumab) X X         X   
MEKTOVI (Binimetinib) X X   X   X    
OXBRYTA (Voxelotor)   X   X   X X  
STEGLATRO (Ertugliflozin) X   X X     X  
TEMODAR INJECTION (Temozolomide) X X   X   X X  
TIBSOVO (Ivosidenib) X X   X   X    
VABYSMO (Faricimab-svoa) X X   X        
ZORTRESS (Everolimus)  X     X X X    
Review more drug monograph updates

]]> September 2023 Recap of Drug Updates https://www.empr.com/home/news/september-2023-recap-of-drug-updates/ Tue, 03 Oct 2023 20:19:29 +0000 https://www.empr.com/?p=207876 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of September. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
COMIRNATY (COVID-19 vaccine) X X   X     X  
COSENTYX (Secukinumab)   X   X     X   
CYLTEZO (Adalimumab-adbm) X X         X   
EZALLOR SPRINKLE (Rosuvastatin [as calcium]) X X X X X      
JARDIANCE (Empagliflozin) X X X  X        
OMECLAMOX-PAK (Omeprazole, clarithromycin, amoxicillin)     X   X     X
SPIKEVAX (COVID-19 vaccine) X X   X     X  
TRINTELLIX (Vortioxetine)       X X   X   
ZEPOSIA (Ozanimod)   X   X   X    
ZOLOFT (Sertraline)       X X   X  
Review more drug monograph updates

]]> Glaucoma Treatment Monographs https://www.empr.com/therapeutic-category/glaucoma/ Wed, 20 Sep 2023 20:39:30 +0000 https://www.empr.com/therapeutic-category/glaucoma/ ]]> ]]> August 2023 Recap of Drug Updates https://www.empr.com/home/news/august-2023-recap-of-drug-updates/ Tue, 05 Sep 2023 17:08:33 +0000 https://www.empr.com/?p=206201 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of August. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
AMJEVITA (Adalimumab-atto) X X         X  
ILARIS (Canakinumab) X X       X    
INGREZZA (Valbenazine) X X   X   X X   
INVOKANA (Canagliflozin) X X X X        
INVOKAMET (Canagliflozin, metformin [as HCl] ext-rel) X X X  X        
LEQEMBI (Lecanemab-irmb)       X X X     
LONSURF (Trifluridine, tipiracil) X X   X        
NESINA (Alogliptin)       X   X    
ZEPZELCA (Lurbinectedin)   X     X      
ZETIA (Ezetimibe) X X X  X X X    
Review more drug monograph updates

]]> July 2023 Recap of Drug Updates https://www.empr.com/home/news/july-2023-recap-of-drug-updates/ Tue, 01 Aug 2023 20:36:31 +0000 https://www.empr.com/?p=201579 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of July. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
BREVIBLOC (Esmolol HCl) X X X X X X    
CLINOLIPID (Lipid content)   X X X        
DROXIA (Hydroxyurea)   X   X        
GAVRETO (Pralsetinib)   X     X      
INTRALIPID (Fat emulsion) X X X  X X   X  
IPOL (Trivalent poliovirus vaccine)   X X X   X  X  
LILETTA (Levonorgestrel) X X X          
RINVOQ (Upadacitinib) X X   X X X    
SAFYRAL (Drospirenone, ethinyl estradiol, levomefolate calcium)     X X X      
ZTALMY (Ganaxolone)   X   X        
Review more drug monograph updates

]]> June 2023 Recap of Drug Updates https://www.empr.com/home/news/drug-monograph-updates/june-2023-recap-of-drug-updates/ Fri, 07 Jul 2023 13:06:31 +0000 https://www.empr.com/?p=200261 The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of June. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
BYLVAY (Odevixibat) X X   X   X    
COREG (Carvedilol)       X X X    
INJECTAFER (Elemental iron [as ferric carboxymaltose]) X X   X        
JARDIANCE (Empagliflozin) X X            
KALYDECO (Ivacaftor) X X     X      
LINZESS (Linaclotide) X X            
PRADAXA (Dabigatran etexilate mesylate)       X   X X  
PREVYMIS (Letermovir) X X            
REXULTI (Brexpiprazole) X X   X        
SYNJARDY (Empagliflozin, metformin HCl) X X            
Review more drug monograph updates

]]> Dry Eye (promo use) https://www.empr.com/drug/systane/#dry-eye Mon, 12 Jun 2023 17:48:57 +0000 Novaliq]]> Novaliq]]> Migraine and Headache Drug Monograph: Propranolol (Promo use) https://www.empr.com/drug/propranolol/#migraine-and-headache Fri, 09 Jun 2023 13:52:45 +0000 Migraine and Headache Drug Monograph: Propranolol]]> Migraine and Headache Drug Monograph: Propranolol]]> Migraine and Headache Drug Monograph: Onzetra Xsail (Promo use) https://www.empr.com/drug/onzetra-xsail/#migraine-and-headache Fri, 09 Jun 2023 13:50:40 +0000 Migraine and Headache Drug Monograph: Onzetra Xsail]]> Migraine and Headache Drug Monograph: Onzetra Xsail]]> Allergies (Promo use) https://www.empr.com/therapeutic-category/allergies/ Thu, 08 Jun 2023 14:53:45 +0000 ]]> ]]> Current and Future Biologics for Severe Allergic Asthma in Children Over 6 Years https://www.empr.com/clinicianpov/asthma-omalizumab-dupilumab-benralizumab-mepolizumab-tezepelumab-biologics/ Mon, 22 May 2023 16:13:04 +0000 ]]> ]]> Identifying Postpartum Depression in Clinical Settings https://www.empr.com/diagnosticupdate/postpartum-depression-anxiety-obsessive-compulsive-psychosis-pregnancy-peripartum/ Mon, 22 May 2023 16:10:24 +0000 ]]> ]]> Migraine and Headache Treatments (Promo Use 2023) https://www.empr.com/charts/migraine-and-headache-treatments/ Thu, 18 May 2023 20:11:21 +0000 Headache pain]]> Headache pain]]>